For a pre-revenue otc listed company - show me what market rate is for convertible debt…
5.0M share sweetener and a discount on opportunistic financing doesn’t create a toxic instrument at all… the debt converts into equity at an above market price almost double what the stock is currently trading at…
Again show everybody an example of non-toxic debt for a pre-revenue otc company…
Unless you know what is and isn’t possible in the capital markets it’s easy to criticize but with no real perspective all this becomes is banter for short scam…
Short scams are the biggest problem in the otc… they hold real companies back from their true potential through misinformation and price suppression tactics
News 
Market Data 
Discover 
